11380 China begins world's first clinical trial of embryonic stem cells

China begins world’s first clinical trial of embryonic stem cells

In two new clinical trials in China will start to use embryonic stem cells for the treatment of Parkinson’s disease and blindness. With them a new set of rules for the use of embryonic stem cells in China and, possibly, will begin a new era of research around the world. The studies surgeons in Zhengzhou, China, will uncover the skull of patients with Parkinson’s disease and to introduce them embryonic stem cells in the brain. About 4 million immature embryonic neural cells will need to remove the debilitating symptoms of Parkinson’s disease. After injection, the skull of patients will be closed and they will return home, where they will wait for the results of treatment.

See also  Meizu announced that the M6 Note
On this topic: ( from category Articles )

Leave feedback

Your email address will not be published. Required fields are marked *